EUVIMEDEUVIMED entdecken
Crossref

CIP2A expression predicts recurrences of tamoxifen-treated breast cancer

Shawn Baldacchino, Laura M Wastall, Christian Saliba, Thomas A Hughes, Christian Scerri, Angelene Berwick, Valerie Speirs, Andrew M Hanby, Godfrey Grech

Tumor Biology · 2017-10 · 39 (10) · 101042831772206

DOI: 10.1177/1010428317722064 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tumor Biology, online erschienen am 15.10.2017. Verfasst von Shawn Baldacchino und 8 weiteren Autor:innen. Beteiligte Einrichtung: 1 Laboratory of Molecular Pathology, Department of Pathology, Faculty of Medicine & Surgery, University of Malta, Msida, Malta. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutoantigensBreast NeoplasmsDisease-Free SurvivalFemaleHumansImmunohistochemistryIntracellular Signaling Peptides and ProteinsMembrane ProteinsNeoplasm Recurrence, LocalPrognosisReceptors, EstrogenTamoxifen

Stichwörter der Autor:innen

CIP2Abreast cancerimmunohistochemistrytamoxifen resistancetissue microarrays

Substanzen

AutoantigensCIP2A protein, humanIntracellular Signaling Peptides and ProteinsMembrane ProteinsReceptors, EstrogenTamoxifen

Autor:innen und Institutionen

  • 1 Laboratory of Molecular Pathology, Department of Pathology, Faculty of Medicine & Surgery, University of Malta, Msida, Malta.
  • 2 School of Medicine, University of Leeds, Leeds, UK.
  • 3 Department of Cellular Pathology, St James's University Hospital, Leeds, UK.
  • 4 Centre for Molecular Medicine and Biobanking, University of Malta, Msida, Malta.
  • 5 Department of Physiology & Biochemistry, Faculty of Medicine & Surgery, University of Malta, Msida, Malta.
  • 6 Leeds Institute of Cancer & Pathology, Faculty of Medicine and Health, University of Leeds, Leeds, UK.

Zitieren

APA

Baldacchino, S., Wastall, L. M., Saliba, C., Hughes, T. A., Scerri, C., Berwick, A., Speirs, V., Hanby, A. M., & Grech, G. (2017). CIP2A expression predicts recurrences of tamoxifen-treated breast cancer. Tumor Biology, 39(10), 101042831772206. https://doi.org/10.1177/1010428317722064

Vancouver

Baldacchino S, Wastall LM, Saliba C, Hughes TA, Scerri C, Berwick A, et al. CIP2A expression predicts recurrences of tamoxifen-treated breast cancer. Tumor Biology. 2017;39(10):101042831772206. doi:10.1177/1010428317722064

BibTeX
@article{Baldacchino2017,
  author = {Baldacchino, Shawn and Wastall, Laura M and Saliba, Christian and Hughes, Thomas A and Scerri, Christian and Berwick, Angelene and Speirs, Valerie and Hanby, Andrew M and Grech, Godfrey},
  title = {CIP2A expression predicts recurrences of tamoxifen-treated breast cancer},
  journal = {Tumor Biology},
  year = {2017},
  volume = {39},
  number = {10},
  pages = {101042831772206},
  doi = {10.1177/1010428317722064}
}
Kostenlos starten →